We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KELYA icon
3301
Kelly Services Class A
KELYA
$514M
$676K ﹤0.01%
29,937
-42,356
-59% -$955K
ENDP
3302
DELISTED
Endo International plc
ENDP
$675K ﹤0.01%
143,905
-5,071
-3% -$22.6K
WNC icon
3303
Wabash National
WNC
$512M
$670K ﹤0.01%
45,592
-12,907
-22% -$192K
CNST
3304
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$669K ﹤0.01%
+14,194
New +$410K
FRTA
3305
DELISTED
Forterra, Inc
FRTA
$667K ﹤0.01%
57,724
+33,832
+142% +$329K
EXTR icon
3306
Extreme Networks
EXTR
$3.94B
$666K ﹤0.01%
90,386
-24,374
-21% -$171K
VECO icon
3307
Veeco
VECO
$3.05B
$666K ﹤0.01%
45,417
-8,606
-16% -$117K
RDVT icon
3308
Red Violet
RDVT
$979M
$665K ﹤0.01%
+35,929
New +$581K
FKO
3309
DELISTED
First Trust South Korea AlphaDEX Fund
FKO
$664K ﹤0.01%
31,913
+6,382
+25% +$128K
KBE icon
3310
CALL
State Street SPDR S&P Bank ETF
KBE
$1.64B
$662K ﹤0.01%
+14,000
New +$634K
AKBA icon
3311
Akebia Therapeutics
AKBA
$354M
$660K ﹤0.01%
104,419
-21,925
-17% -$104K
SMP icon
3312
Standard Motor Products
SMP
$851M
$659K ﹤0.01%
12,405
-2,955
-19% -$151K
NGG icon
3313
National Grid
NGG
$80.4B
$657K ﹤0.01%
+11,849
New +$609K
CRMT icon
3314
America's Car Mart
CRMT
$26.6M
$655K ﹤0.01%
5,976
+669
+13% +$64.7K
AEG icon
3315
Aegon
AEG
$14B
$652K ﹤0.01%
+156,013
New +$637K
MYRG icon
3316
MYR Group
MYRG
$5.19B
$651K ﹤0.01%
19,962
+2,737
+16% +$90.4K
ASG
3317
Liberty All-Star Growth Fund
ASG
$328M
$650K ﹤0.01%
+100,000
New +$612K
TKC icon
3318
Turkcell
TKC
$4.68B
$649K ﹤0.01%
111,887
+42,902
+62% +$245K
TVTY
3319
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$649K ﹤0.01%
31,912
-1,813
-5% -$33.9K
TCX icon
3320
Tucows
TCX
$172M
$648K ﹤0.01%
10,493
-650
-6% -$37.1K
EWJ icon
3321
CALL
iShares MSCI Japan ETF
EWJ
$21.9B
$646K ﹤0.01%
10,900
-11,900
-52% -$701K
SLCA
3322
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$646K ﹤0.01%
105,246
+35,286
+50% +$213K
MMI icon
3323
Marcus & Millichap
MMI
$1.16B
$644K ﹤0.01%
17,318
-3,461
-17% -$124K
ARCT icon
3324
Arcturus Therapeutics
ARCT
$164M
$641K ﹤0.01%
+59,003
New +$618K
NCMI icon
3325
National CineMedia
NCMI
$376M
$640K ﹤0.01%
8,769
+2,884
+49% +$217K

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.